(HealthDay News) — Here are the latest clinical trials, courtesy of CenterWatch:

Leukemia

In this study, patients who have never received imatinib for CML will be given either the st seo services andard 400 mg dose of imatinib or the higher study drug dose of 800 mg of imatinib. A “study drug” is a drug that is being tested and is not approved for sale by the U.S. Food and Drug Administration (FDA). Participants must meet the following criteria: ability to provide written informed consent prior to participation, male or female between 18 and 75 years of age, and within six months of diagnosis (the date of first cytogenetic analysis). Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat92.html.

—–

Diabetes – Type 2

Our clinic is testing a new and investigational medicine for Type 2 diabetes mellitus. You may qualify if you have Type 2 diabetes, are 18-75 years old, use a single oral medication such as Amaryl, Glucotrol, Prandin, Acarbose or Glucophage, or do not currently use any diabetes medication. Research site located in Long Beach, Calif.

More Information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

—–

Menstrual Disorders

This is a 12-month study for women with heavy menstrual bleeding (menorrhagia). There will be nine office visits and one phone call. You may qualify for this clinical study if you are a woman ages 18-49 with heavy menstrual bleeding and you have regularly occurring menstrual periods with 21-35 days between cycles (for at least six months). Research site located in Ocala, Fla.

More Information

Please see http://www.centerwatch.com/patient/studies/cat299.html.

—–

Copyright 2005 CenterWatch. All rights reserved.